UK markets closed
  • NIKKEI 225

    23,494.34
    -22.25 (-0.09%)
     
  • HANG SENG

    24,918.78
    +132.68 (+0.54%)
     
  • CRUDE OIL

    38.60
    -1.25 (-3.14%)
     
  • GOLD FUTURES

    1,904.50
    -0.70 (-0.04%)
     
  • DOW

    27,685.38
    -650.19 (-2.29%)
     
  • BTC-GBP

    10,005.69
    -68.67 (-0.68%)
     
  • CMC Crypto 200

    260.00
    -3.41 (-1.30%)
     
  • ^IXIC

    11,358.94
    -189.34 (-1.64%)
     
  • ^FTAS

    3,271.08
    -39.30 (-1.19%)
     

Pediatric Vaccines Market Research Report by Technology, by Vaccine Type, by End User, by Indication - Global Forecast to 2025 - Cumulative Impact of COVID-19

ReportLinker
·5-min read

Pediatric Vaccines Market Research Report by Technology (Attenuated Live Viruses, Conjugates, Inactivated Viruses, Polysaccharides, and Recombinant), by Vaccine Type (Monovalent and Multivalent), by End User, by Indication - Global Forecast to 2025 - Cumulative Impact of COVID-19

New York, Sept. 24, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Pediatric Vaccines Market Research Report by Technology, by Vaccine Type, by End User, by Indication - Global Forecast to 2025 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p05941588/?utm_source=GNW

The Global Pediatric Vaccines Market is expected to grow from USD 12,943.26 Million in 2019 to USD 22,869.61 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 9.95%.

Market Segmentation & Coverage:
This research report categorizes the Pediatric Vaccines to forecast the revenues and analyze the trends in each of the following sub-markets:

"The Conjugates is projected to witness the highest growth during the forecast period"

Based on Technology, the Pediatric Vaccines Market studied across Attenuated Live Viruses, Conjugates, Inactivated Viruses, Polysaccharides, Recombinant, Subunits, and Toxoids. The Attenuated Live Viruses commanded the largest size in the Pediatric Vaccines Market in 2019. On the other hand, the Conjugates is expected to grow at the fastest CAGR during the forecast period.

"The Multivalent is projected to witness the highest growth during the forecast period"

Based on Vaccine Type, the Pediatric Vaccines Market studied across Monovalent and Multivalent. The Multivalent commanded the largest size in the Pediatric Vaccines Market in 2019, and it is expected to grow at the fastest CAGR during the forecast period.

"The Pediatric Clinic is projected to witness the highest growth during the forecast period"

Based on End User, the Pediatric Vaccines Market studied across Hospital, Pediatric Clinic, and Research Organization. The Pediatric Clinic commanded the largest size in the Pediatric Vaccines Market in 2019, and it is expected to grow at the fastest CAGR during the forecast period.

"The Haemophilus Influenzae Type B is projected to witness the highest growth during the forecast period"

Based on Indication, the Pediatric Vaccines Market studied across Haemophilus Influenzae Type B, Hepatitis, Human papillomavirus (HPV), Measles, Meningitis A, Mumps, Pneumococcal Diseases, Polio, Rotaviruses, Rubella, Tetanus, and Yellow Fever. The Pneumococcal Diseases commanded the largest size in the Pediatric Vaccines Market in 2019. On the other hand, the Haemophilus Influenzae Type B is expected to grow at the fastest CAGR during the forecast period.

"The Asia-Pacific is projected to witness the highest growth during the forecast period"

Based on Geography, the Pediatric Vaccines Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded the largest size in the Pediatric Vaccines Market in 2019. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.

Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Pediatric Vaccines Market including AstraZeneca PLC, CSL Limited, Eli Lilly and Company, GlaxoSmithKline PLC, Merck Sharp & Dohme Corp., Mitsubishi Chemical Corporation, Novartis AG, Pfizer Inc., Sanofi S.A., and Serum Institute of India Pvt. Ltd..

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Pediatric Vaccines Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Pediatric Vaccines Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Pediatric Vaccines Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Pediatric Vaccines Market?
4. What is the competitive strategic window for opportunities in the Global Pediatric Vaccines Market?
5. What are the technology trends and regulatory frameworks in the Global Pediatric Vaccines Market?
6. What are the modes and strategic moves considered suitable for entering the Global Pediatric Vaccines Market?
Read the full report: https://www.reportlinker.com/p05941588/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001